{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:34:03Z","timestamp":1781796843573,"version":"3.54.5"},"reference-count":52,"publisher":"The Japan Society of Coloproctology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Anus Rectum Colon"],"published-print":{"date-parts":[[2025,1,25]]},"DOI":"10.23922\/jarc.2024-035","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T22:12:52Z","timestamp":1737756772000},"page":"69-78","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic Impact of the Postoperative Carcinoembryonic Antigen Level after Curative Resection of Locally Advanced Rectal Cancer"],"prefix":"10.23922","volume":"9","author":[{"given":"Ryoichi","family":"Tsukamoto","sequence":"first","affiliation":[{"name":"Department of Coloproctological Surgery, Juntendo University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiichi","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Department of Coloproctological Surgery, Juntendo University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ii","sequence":"additional","affiliation":[{"name":"Department of Coloproctological Surgery, Juntendo University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Irie","sequence":"additional","affiliation":[{"name":"Department of Coloproctological Surgery, Juntendo University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Department of Coloproctological Surgery, Juntendo University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Kobari","sequence":"additional","affiliation":[{"name":"Department of Coloproctological Surgery, Juntendo University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"Department of Coloproctological Surgery, Juntendo University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumpei","family":"Honjo","sequence":"additional","affiliation":[{"name":"Department of Coloproctological Surgery, Juntendo University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Kawai","sequence":"additional","affiliation":[{"name":"Department of Coloproctological Surgery, Juntendo University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Ishiyama","sequence":"additional","affiliation":[{"name":"Department of Coloproctological Surgery, Juntendo University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Coloproctological Surgery, Juntendo University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Coloproctological Surgery, Juntendo University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10009","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022 Jan;72 (1):7-33.","DOI":"10.3322\/caac.21708"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Carioli G, Malvezzi M, Bertuccio P, et al. Cancer mortality in the elderly in 11 countries worldwide, 1970-2015. Ann Oncol 2019 Aug;30 (8):1344-55.","DOI":"10.1093\/annonc\/mdz178"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Schlechter BL: Management of rectal cancer. Hematol Oncol Clin North Am. 2022 Jun;36 (3):521-37.","DOI":"10.1016\/j.hoc.2022.03.002"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Fokas E, Glynne-Jones R, Appelt A, et al. Outcome measures in multimodal rectal cancer trials. Lancet Oncol. 2020 May;21 (5):e252-64.","DOI":"10.1016\/S1470-2045(20)30024-3"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Guida AM, Sensi B, Formica V, et al. Total neoadjuvant therapy for the treatment of locally advanced rectal cancer: a systematic minireview. Biol Direct. 2022 Jun ;17 (1):16.","DOI":"10.1186\/s13062-022-00329-7"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Lee HH, Chen CH, Huang YH, et al. Biomarkers of favorable vs. unfavorable responses in locally advanced rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy. Cells. 2022 Apr;11 (10).","DOI":"10.3390\/cells11101611"},{"key":"7","unstructured":"7. Iv AA, Koprowski MA, Nabavizadeh N, et al. The evolution of rectal cancer treatment: the journey to total neoadjuvant therapy and organ preservation. Ann Gastroenterol. 2022 Apr;35 (3):226-33."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sugihara K, Kobayashi H, Kato T, et al. Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum. 2006 Nov;49 (11):1663-72.","DOI":"10.1007\/s10350-006-0714-z"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Akiyoshi T, Watanabe T, Miyata S, et al. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease? Ann Surg. 2012 Jun;255 (6):1129-34.","DOI":"10.1097\/SLA.0b013e3182565d9d"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tokuhara K, Matsui Y, Ueyama Y, et al. Feasibility and efficacy of neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer. J Anus Rectum Colon. 2022 Jan;6 (1):24-31.","DOI":"10.23922\/jarc.2021-033"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001 Aug;345 (9):638-46.","DOI":"10.1056\/NEJMoa010580"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007 Nov;246 (5):693-701.","DOI":"10.1097\/01.sla.0000257358.56863.ce"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009 Mar;373 (9666):811-20.","DOI":"10.1016\/S0140-6736(09)60484-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. R\u00f6del C, Liersch T, Becker H, et al. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO\/ARO\/AIO-04 randomised phase 3 trial. Lancet Oncol. 2012 May;13 (7): 679-87.","DOI":"10.1016\/S1470-2045(12)70187-0"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. van der Meij W, Rombouts AJ, R\u00fctten H, et al. Treatment of locally recurrent rectal carcinoma in previously (chemo) irradiated patients: a review. Dis Colon Rectum. 2016 Feb;59 (2):148-56.","DOI":"10.1097\/DCR.0000000000000547"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011 May;12 (6):575-82.","DOI":"10.1016\/S1470-2045(11)70097-3"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Fokas E, Liersch T, Fietkau R, et al. Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO\/ARO\/AIO-94 trial. J Clin Oncol. 2014 Apr;32 (15):1554-62.","DOI":"10.1200\/JCO.2013.54.3769"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Mendis S, To YH and Tie J: Biomarkers in locally advanced rectal cancer: a review. Clin Colorectal Cancer. 2022 Mar;21 (1):36-44.","DOI":"10.1016\/j.clcc.2021.11.002"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Beppu N, Ikeda M, Kataoka K, et al. Total neoadjuvant chemotherapy in rectal cancer: current facts and future strategies. J Anus Rectum Colon. 2023 Jan;7 (1):1-7.","DOI":"10.23922\/jarc.2022-060"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kakizoe M, Watanabe J, Goto K, et al. Identification of patients with locally advanced rectal cancer in whom preoperative radiotherapy can be omitted: A multicenter retrospective study at Yokohama clinical oncology group (YCOG1307). J Anus Rectum Colon. 2021 Apr;5 (2):173-80.","DOI":"10.23922\/jarc.2020-084"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Gold P, Freedman SO: Specific carcinoembryonic antigens of the human digestive system. J Exp Med. 1965 Sep;122 (3):467-81.","DOI":"10.1084\/jem.122.3.467"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Holyoke ED, Chu TM, Murphy GP: CEA as a monitor of gastrointestinal malignancy. Cancer. 1975 Mar;35 (3):830-6.","DOI":"10.1002\/1097-0142(197503)35:3<830::AID-CNCR2820350340>3.0.CO;2-H"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Livingstone AS, Hampson LG, Shuster J, et al. Carcinoembryonic antigen in the diagnosis and management of colorectal carcinoma. Current status. Arch Surg. 1974 Aug;109 (2):259-64.","DOI":"10.1001\/archsurg.1974.01360020119023"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Primrose JN, Perera R, Gray A, et al. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA. 2014 Jan;311 (3):263-70.","DOI":"10.1001\/jama.2013.285718"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Bhatti I, Patel M, Dennison AR, et al. Utility of postoperative CEA for surveillance of recurrence after resection of primary colorectal cancer. Int J Surg. 2015 Apr;16 (A):123-8.","DOI":"10.1016\/j.ijsu.2015.03.002"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Takahashi R, Sakamoto K, Sugimoto K, et al. Significance of serum p53 antibody as a tumor marker in colorectal cancer. Dis Markers. [Internet].2019 Nov 26 [cited 2019 Dec 16]: 2721876. Available from: https:\/\/doi.org\/10.1155\/2019\/2721876.","DOI":"10.1155\/2019\/2721876"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Wang WS, Lin JK, Lin TC, et al. Carcinoembryonic antigen in monitoring of response to systemic chemotherapy in patients with metastatic colorectal cancer. Int J Colorectal Dis. 2014 Jul;16 (2):96-101.","DOI":"10.1007\/s003840000266"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Arrieta O, Villarreal-Garza C, Mart\u00ednez-Barrera L, et al. Usefulness of serum carcinoembryonic antigen (CEA) in evaluating response to chemotherapy in patients with advanced non small-cell lung cancer: a prospective cohort study. BMC Cancer. 2013 May;13:254.","DOI":"10.1186\/1471-2407-13-254"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Sonoda H, Yamada T, Matsuda A, et al. Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer. Eur J Surg Oncol. 2021 Nov;47 (11):2880-7.","DOI":"10.1016\/j.ejso.2021.05.041"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Margalit O, Mamtani R, Yang YX, et al. Assessing the prognostic value of carcinoembryonic antigen levels in stage I and II colon cancer. Eur J Cancer. 2018 Mar;94:1-5.","DOI":"10.1016\/j.ejca.2018.01.112"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Japanese Society for Cancer of the Colon and Rectum: Japanese classification of colorectal, appendiceal, and anal carcinoma: the 3d English edition [Secondary Publication]. J Anus Rectum Colon. 2019 Oct;3 (4):175-95.","DOI":"10.23922\/jarc.2019-018"},{"key":"32","unstructured":"32. Hashiguchi Y, Muro K, Saito Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020 Jun;25 (1):1-42."},{"key":"33","unstructured":"33. Delaney CP, Neary PC, Heriot AG, et al. Operative Techniques in Laparoscopic Colorectal Surgery, 2nd ed. Philadelphia: Lippincott Williams &amp; Wilkins;2013."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Sugimoto K, Sakamoto K, Tsuchiya T, et al. Prognostic factors in patients with high-risk stage II colon cancer after curative resection: a post hoc analysis of the JFMC46-1201 trial. Int J Colorectal Dis. 2023 Oct;38 (1):260.","DOI":"10.1007\/s00384-023-04559-7"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Brierley JD, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours, 8th edn. Hoboken, John Wiley &amp; Sons;2017.","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Agger E, J\u00f6rgren F, Lydrup ML, et al. Circumferential resection margin is associated with distant metastasis after rectal cancer surgery: A nation-wide population-based study cohort. Ann Surg. 2023 Feb;277 (2):e346-e352.","DOI":"10.1097\/SLA.0000000000005302"},{"key":"37","unstructured":"37. Akaike H. Information theory and an extension of the maximum likelihood principle. In: B.N.Petrov editor. Second International Symposium on Information Theory. Budapest: Akademiai Kiado, 1973:267-281."},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Zhao JY, Tang QQ, Luo YT, et al. Predictive value of a serum tumor biomarkers scoring system for clinical stage II\/III rectal cancer with neoadjuvant chemoradiotherapy. World J Gastrointest Oncol.2022 Oct;14 (10):2014-24.","DOI":"10.4251\/wjgo.v14.i10.2014"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Paku M, Uemura M, Kitakaze M, et al. Clinical significance of preoperative and postoperative serum CEA and carbohydrate antigen 19-9 levels in patients undergoing curative resection of locally recurrent rectal cancer. Dis Colon Rectum. 2023 Mar;66 (3):392-400.","DOI":"10.1097\/DCR.0000000000002655"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Lin JK, Lin CC, Yang SH, et al. Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer. Int J Colorectal Dis. 2011 May;26 (9):1135-41.","DOI":"10.1007\/s00384-011-1209-5"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Kwaan MR. Postoperative CEA and other non-traditional risk factors for colon cancer recurrence: findings from Swedish population-based data. Ann Surg Oncol.2020 Dec;27 (4):971-2.","DOI":"10.1245\/s10434-019-08151-8"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Yoshino K, Osumi H, Ito H, et al. Clinical usefulness of postoperative serum carcinoembryonic antigen in patients with colorectal cancer with liver metastases. Ann Surg Oncol. 2022 Aug;29 (13):8385-93.","DOI":"10.1245\/s10434-022-12301-w"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Pantel K, Alix-Panabi\u00e8res C. Liquid biopsy and minimal residual disease - latest advances and implications for cure. Nat Rev Clin Oncol. 2019 Feb;16 (7):409-24.","DOI":"10.1038\/s41571-019-0187-3"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Sonoda H, Yamada T, Matsuda A, et al. The T-CEA score: a useful prognostic indicator based on postoperative CEA and pathological T4 levels for patients with stage II-III colorectal cancer. Surg Today. 2023 Aug;53 (8):890-8.","DOI":"10.1007\/s00595-023-02644-6"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Konishi T, Shimada Y, Hsu M, et al. Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome. JAMA Oncol. 2018 Mar;4 (3):309-15.","DOI":"10.1001\/jamaoncol.2017.4420"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Faulkner LG, Howells LM, Pepper C, et al. The utility of ctDNA in detecting minimal residual disease following curative surgery in colorectal cancer: a systematic review and meta-analysis. Br J Cancer. 2023 Nov;128 (2):297-309.","DOI":"10.1038\/s41416-022-02017-9"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Hida K, Okamura R, Park SY, et al. A new prediction model for local recurrence after curative rectal cancer surgery: development and validation as an Asian collaborative study. Dis Colon Rectum. 2017 Nov;60 (11):1168-74.","DOI":"10.1097\/DCR.0000000000000896"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Gunderson LL, Jessup JM, Sargent DJ, et al. Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes. J Clin Oncol. 2010 Jan;28 (2):256-63.","DOI":"10.1200\/JCO.2009.23.9194"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Argil\u00e9s G, Tabernero J, Labianca R, et al. Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020 Oct;31 (10):1291-305.","DOI":"10.1016\/j.annonc.2020.06.022"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Oki E, Murata A, Yoshida K, et al. A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II\/III rectal cancer (JFMC35-C1: ACTS-RC). Ann Oncol. 2016 Jul;27 (7):1266-72.","DOI":"10.1093\/annonc\/mdw162"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Mizushima T, Ikeda M, Kato T, et al. Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II study. BMC Cancer. 2019 Sep;19 (1):929.","DOI":"10.1186\/s12885-019-6122-2"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Fukuda I, Yamakado M, Kiyose H. Influence of smoking on serum carcinoembryonic antigen levels in subjects who underwent multiphasic health testing and services. J Med Syst. 1998 Apr;22 (2):89-93.","DOI":"10.1023\/A:1022643102208"}],"container-title":["Journal of the Anus, Rectum and Colon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/9\/1\/9_2024-035\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T04:54:52Z","timestamp":1737780892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/9\/1\/9_2024-035\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,25]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.23922\/jarc.2024-035","relation":{},"ISSN":["2432-3853"],"issn-type":[{"value":"2432-3853","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,25]]},"article-number":"2024-035"}}